4.2 Article

Botulinum toxin to improve facial expression in a patient with Urofacial (Ochoa) Syndrome

Journal

AMERICAN JOURNAL OF MEDICAL GENETICS PART A
Volume 191, Issue 2, Pages 559-563

Publisher

WILEY
DOI: 10.1002/ajmg.a.63025

Keywords

Botulinum toxin; facial expression; Ochoa Syndrome

Ask authors/readers for more resources

The Urofacial or Ochoa Syndrome is a rare congenital disorder that affects both the urinary system and facial expression. This study reports the successful use of Botulinum toxin to address the impaired facial mimicry in a patient with this syndrome.
The Urofacial or Ochoa Syndrome is a very rare congenital disorder that includes vesical bladder dysfunction and a peculiar inverse facial expression, which brings patients to express a sad-crying face while they intend to laugh. Up-to-date treatments have addressed only the urological side of this disease. However, also the impaired facial mimicry has a strong impact on patients' quality of life. We treated a young patient with Botulinum toxin to address this impairment and obtained pleasing results, including a harmonic smile and a very satisfied patient. To the best of our knowledge, this is the first time that the use of Botulinum toxin is reported in literature to address the facial expression component of this disease.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.2
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available